Literature DB >> 20865463

Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?

Yong-Chan Ha1, Myung-Rae Cho, Ki Hong Park, Shin-Yoon Kim, Kyung-Hoi Koo.   

Abstract

BACKGROUND: Prolonged use of bisphosphonates in patients with osteoporosis reportedly induces femoral insufficiency fractures. However, the natural course of these fractures and how to treat them remain unknown. QUESTIONS/PURPOSES: We determined the rates of fracture displacement and subsequent operations of undisplaced insufficiency fractures of the femur in patients treated with prolonged bisphosphonate therapy. PATIENTS AND METHODS: We retrospectively collected and reviewed the clinical course of 11 patients (14 fractures) who had been diagnosed as having an insufficiency fracture of the femur after prolonged use (mean, 4.5 years; range, 3-10 years) of bisphosphonate. All patients were women with a mean age of 68 years (range, 57-82 years). The fracture site was subtrochanteric in six and femoral shaft in eight. The minimum followup was 12 months (mean, 27 months; range, 12-60 months).
RESULTS: During the followup period, secondary displacement of the fracture occurred in five of the 14 fractures after a mean of 10 months (range, 1-19 months). Three fractures were treated with internal fixation using a compression hip screw and two with intramedullary nailing. Because five additional fractures were treated surgically owing to intractable pain, surgery was performed in 10 of 14 insufficiency fractures during the followup period. All 10 fractures healed during followup. The remaining four patients (four fractures) not undergoing any surgery had persistent pain.
CONCLUSIONS: Femoral insufficiency fractures after prolonged bisphosphonate therapy seldom healed spontaneously and most patients had surgery either for fracture displacement or persistent pain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865463      PMCID: PMC2974881          DOI: 10.1007/s11999-010-1583-2

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  23 in total

1.  Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

Authors:  Dennis M Black; Michael P Kelly; Harry K Genant; Lisa Palermo; Richard Eastell; Christina Bucci-Rechtweg; Jane Cauley; Ping Chung Leung; Steven Boonen; Arthur Santora; Anne de Papp; Douglas C Bauer
Journal:  N Engl J Med       Date:  2010-03-24       Impact factor: 91.245

2.  Insufficiency fracture of the femoral neck during osteoporosis treatment: a case report.

Authors:  Jun Iwamoto; Tsuyoshi Takeda
Journal:  J Orthop Sci       Date:  2002       Impact factor: 1.601

Review 3.  Low-risk stress fractures.

Authors:  B P Boden; D C Osbahr; C Jimenez
Journal:  Am J Sports Med       Date:  2001 Jan-Feb       Impact factor: 6.202

4.  Acceleration of tibial fracture-healing by non-invasive, low-intensity pulsed ultrasound.

Authors:  J D Heckman; J P Ryaby; J McCabe; J J Frey; R F Kilcoyne
Journal:  J Bone Joint Surg Am       Date:  1994-01       Impact factor: 5.284

5.  Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

Authors:  T Mashiba; T Hirano; C H Turner; M R Forwood; C C Johnston; D B Burr
Journal:  J Bone Miner Res       Date:  2000-04       Impact factor: 6.741

6.  Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles.

Authors:  T Mashiba; C H Turner; T Hirano; M R Forwood; C C Johnston; D B Burr
Journal:  Bone       Date:  2001-05       Impact factor: 4.398

7.  Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra.

Authors:  Satoshi Komatsubara; Satoshi Mori; Tasuku Mashiba; Masako Ito; Jiliang Li; Yoshio Kaji; Tomoyuki Akiyama; Kensaku Miyamoto; Yongping Cao; Jun Kawanishi; Hiromichi Norimatsu
Journal:  J Bone Miner Res       Date:  2003-03       Impact factor: 6.741

8.  Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

Authors:  R Eastell; I Barton; R A Hannon; A Chines; P Garnero; P D Delmas
Journal:  J Bone Miner Res       Date:  2003-06       Impact factor: 6.741

9.  Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib.

Authors:  Satoshi Komatsubara; Satoshi Mori; Tasuku Mashiba; Jilliang Li; Kiichi Nonaka; Yoshio Kaji; Tomoyuki Akiyama; Kensaku Miyamoto; Yongping Cao; Jun Kawanishi; Hiromichi Norimatsu
Journal:  J Bone Miner Res       Date:  2004-01-19       Impact factor: 6.741

10.  Ten years' experience with alendronate for osteoporosis in postmenopausal women.

Authors:  Henry G Bone; David Hosking; Jean-Pierre Devogelaer; Joseph R Tucci; Ronald D Emkey; Richard P Tonino; Jose Adolfo Rodriguez-Portales; Robert W Downs; Jayanti Gupta; Arthur C Santora; Uri A Liberman
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245

View more
  49 in total

1.  Bisphosphonate-associated femur fractures have high complication rates with operative fixation.

Authors:  Mark L Prasarn; Jaimo Ahn; David L Helfet; Joseph M Lane; Dean G Lorich
Journal:  Clin Orthop Relat Res       Date:  2012-06-06       Impact factor: 4.176

Review 2.  Atypical femoral fractures: epidemiology, etiology, and patient management.

Authors:  Eve Donnelly; Anas Saleh; Aasis Unnanuntana; Joseph M Lane
Journal:  Curr Opin Support Palliat Care       Date:  2012-09       Impact factor: 2.302

Review 3.  Surgical Treatment of the Atypical Femoral Fracture: Overcoming Femoral Bowing.

Authors:  Kyung-Jae Lee; Byung-Woo Min
Journal:  Hip Pelvis       Date:  2018-12-06

Review 4.  Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Y-T Li; H-F Cai; Z-L Zhang
Journal:  Osteoporos Int       Date:  2014-09-30       Impact factor: 4.507

Review 5.  Review: epidemiology and pathophysiology of atypical femur fractures.

Authors:  Alvin C Ng; Meng Ai Png; David T Chua; Joyce S B Koh; Tet Sen Howe
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

6.  Spontaneous Insufficiency Fractures.

Authors:  M Brennan; P M O'Shea; S T O'Keeffe; E C Mulkerrin
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 7.  Atypical femoral fractures: a review of the literature.

Authors:  Pingal A Desai; Parth A Vyas; Joseph M Lane
Journal:  Curr Osteoporos Rep       Date:  2013-09       Impact factor: 5.096

Review 8.  Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.

Authors:  Beatrice J Edwards; Andrew D Bunta; Joseph Lane; Clarita Odvina; D Sudhaker Rao; Dennis W Raisch; June M McKoy; Imran Omar; Steven M Belknap; Vishvas Garg; Allison J Hahr; Athena T Samaras; Matthew J Fisher; Dennis P West; Craig B Langman; Paula H Stern
Journal:  J Bone Joint Surg Am       Date:  2013-02-20       Impact factor: 5.284

9.  Atypical femoral fractures after anti-osteoporotic medication: a Korean multicenter study.

Authors:  Joon Soon Kang; Ye Yeon Won; Jong Oh Kim; Byeong Woo Min; Kee Haeng Lee; Kwan Kyu Park; Joo Hyun Song; Young Tae Kim; Geon Ho Kim
Journal:  Int Orthop       Date:  2014-01-25       Impact factor: 3.075

10.  Management strategy for symptomatic bisphosphonate-associated incomplete atypical femoral fractures.

Authors:  Anas Saleh; Vishal V Hegde; Anish G Potty; Robert Schneider; Charles N Cornell; Joseph M Lane
Journal:  HSS J       Date:  2012-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.